Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab in Severe Chronic Hand Eczema
NCT04512339Phase 2Unknown
- Sponsor
- University Medical Center Groningen
- Start
- Aug 2020
- Primary completion
- Aug 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of dupilumab in chronic hand eczema (CHE), sponsored by University Medical Center Groningen. Status: unknown.
02
Drugs
03
Conditions
chronic hand eczema (CHE)
Beyond the preview
Go deeper on NCT04512339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512339.